Not applicableEnded earlyNCT00146029What this trial is testingCompanion Pharmacogenetic Study to UMCC 9900/9901Who this might be right forMetastatic Breast Cancer University of Michigan Rogel Cancer Center
Early research (Phase 1)Study completedNCT05344729What this trial is testingClinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult SubjectsWho this might be right forRecurrent/Metastatic Breast Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 16
Testing effectiveness (Phase 2)Ended earlyNCT04720729What this trial is testingChemotherapy Monitoring by ctDNA in HER2- Metastatic Breast CancerWho this might be right forHER2-negative Metastatic Breast Cancer Institut Curie 160
Early research (Phase 1)Study completedNCT05052437What this trial is testingPK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast CancerWho this might be right forAdvanced and Metastatic Breast Cancer Beijing Biostar Pharmaceuticals Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT00662129What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 50
Not applicableStudy completedNCT01920139What this trial is testingUltrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary LymphadenopathyWho this might be right forFocus: Breast Cancer With Axillary Node Metastasis University of Pittsburgh 105
Not applicableStudy completedNCT02948751What this trial is testingMicrofluidic Device to Diagnose Leptomeningeal Metastasis in Breast CancerWho this might be right forBreast CancerLeptomeningeal Metastasis Columbia University 14
Not applicableLooking for participantsNCT03824145What this trial is testingEvery Day Counts: A Lifestyle Program for Women With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Medical College of Wisconsin 176
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Not applicableUnknownNCT00682253What this trial is testingUse of Bone Scintigraphy, CT and MRI in Breast CancerWho this might be right forBreast Neoplasms University of Aarhus 180
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Not applicableLooking for participantsNCT05378204What this trial is testingStudy Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.Who this might be right forBreast Cancer Institut Claudius Regaud 120
Not applicableWithdrawnNCT01936961What this trial is testingStudy of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid TumorsWho this might be right forMetastatic Non-Small Cell Lung CancerMetastatic Colon CancerMetastatic Triple Negative Breast Cancer Western Regional Medical Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04739761What this trial is testingT-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast CancerWho this might be right forBreast Cancer AstraZeneca 506
Testing effectiveness (Phase 2)Study completedNCT05383170What this trial is testingEvaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic CancersWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Breast CancerAdvanced Melanoma Cytovation AS 6
Large-scale testing (Phase 3)Study completedNCT01808573What this trial is testingNeratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic SettingWho this might be right forHER2+ Metastatic Breast Cancer (MBC) Puma Biotechnology, Inc. 621
Testing effectiveness (Phase 2)Study completedNCT02491983What this trial is testingPalbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast CancerWho this might be right forMetastatic Breast Cancer MedSIR 486
Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Not applicableStudy completedNCT00624156What this trial is testingExpressive Writing and Adjustment to Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Memorial Sloan Kettering Cancer Center 98
Testing effectiveness (Phase 2)Study completedNCT03633331What this trial is testingPalbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7 Alliance for Clinical Trials in Oncology 93